<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wu H</submitter><funding>The Guangdong Basic and Applied Basic Research Foundation</funding><funding>The Natural Science Foundation for Distinguished Young Scholars of Guangdong Province</funding><funding>The Climbing Program of Introduced Talents and High-level Hospital Construction Project of Guangdong Provincial People’s Hospital</funding><funding>The Program for High-level Foreign Expert Introduction of China</funding><funding>The Climbing Program of Introduced Talents and High-level Hospital Construction Project of Guangdong Provincial People's Hospital</funding><funding>The National Natural Science Foundation of China</funding><pagination>68</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9822216</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>28(1)</volume><pubmed_abstract>Ulcerative colitis is a chronic inflammatory bowel disorder that is hard to cure once diagnosed. Bisdemethoxycurcumin has shown positive effects on inflammatory diseases. However, the underlying bioactive interaction between bisdemethoxycurcumin and ulcerative colitis is unclear. The objective of this study was to determine the core target and potential mechanism of action of bisdemethoxycurcumin as a therapy for ulcerative colitis. The public databases were used to identify potential targets for bisdemethoxycurcumin and ulcerative colitis. To investigate the potential mechanisms, the protein-protein interaction network, gene ontology analysis, and Kyoto encyclopedia of genes and genomes analysis have been carried out. Subsequently, experimental verification was conducted to confirm the fi</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Investigating the Mechanisms of Bisdemethoxycurcumin in Ulcerative Colitis: Network Pharmacology and Experimental Verification.</pubmed_title><pmcid>PMC9822216</pmcid><funding_grant_id>DFJH201803, KJ012019099, KJ012021143, KY012021183</funding_grant_id><funding_grant_id>2021B1515020003</funding_grant_id><funding_grant_id>KY012021183</funding_grant_id><funding_grant_id>81300279</funding_grant_id><funding_grant_id>82171698</funding_grant_id><funding_grant_id>KJ012021143</funding_grant_id><funding_grant_id>81300279,8174106782171698, 82170561</funding_grant_id><funding_grant_id>82170561</funding_grant_id><funding_grant_id>DFJH201803</funding_grant_id><funding_grant_id>81741067</funding_grant_id><funding_grant_id>2022A1515012081</funding_grant_id><funding_grant_id>G2022030047L</funding_grant_id><funding_grant_id>KJ012019099</funding_grant_id><pubmed_authors>Zeng R</pubmed_authors><pubmed_authors>Sha W</pubmed_authors><pubmed_authors>Tu S</pubmed_authors><pubmed_authors>Zhuo Z</pubmed_authors><pubmed_authors>Jiang R</pubmed_authors><pubmed_authors>Yang Q</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Lian Q</pubmed_authors><pubmed_authors>Wu H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Investigating the Mechanisms of Bisdemethoxycurcumin in Ulcerative Colitis: Network Pharmacology and Experimental Verification.</name><description>Ulcerative colitis is a chronic inflammatory bowel disorder that is hard to cure once diagnosed. Bisdemethoxycurcumin has shown positive effects on inflammatory diseases. However, the underlying bioactive interaction between bisdemethoxycurcumin and ulcerative colitis is unclear. The objective of this study was to determine the core target and potential mechanism of action of bisdemethoxycurcumin as a therapy for ulcerative colitis. The public databases were used to identify potential targets for bisdemethoxycurcumin and ulcerative colitis. To investigate the potential mechanisms, the protein-protein interaction network, gene ontology analysis, and Kyoto encyclopedia of genes and genomes analysis have been carried out. Subsequently, experimental verification was conducted to confirm the fi</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-04-08T11:16:06.405Z</modification><creation>2025-02-18T22:34:20.638Z</creation></dates><accession>S-EPMC9822216</accession><cross_references><pubmed>36615264</pubmed><doi>10.3390/molecules28010068</doi></cross_references></HashMap>